Raymond James Financial’s Evotec EVO Stock Holding History

Raymond James Financial’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,178	Closed	-$9.15K	–	5534
2025 Q2	$9.15K	Buy	+2,178	New	+$8.54K	﹤0.01%	5954

Other funds holding EVO

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Pitcairn Conshohocken, Pennsylvania $1.27B AUM 23.64% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial's EVO Position: Q3 2025 in Review

Raymond James Financial sold out of Evotec (EVO) in Q3 2025, closing a stake of 2,178 shares — an estimated $9.15K sold.

Raymond James Financial first reported a position in EVO in Q2 2025 and held it in 1 quarter. The position peaked at $9.15K in Q2 2025. 37 funds tracked by Wall St. Rank hold EVO as of Q3 2025.

Raymond James Financial reported no remaining Evotec position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 2,178 Evotec shares in Q3 2025, an estimated $9.15K.
Raymond James Financial first reported a position in Evotec in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Evotec position peaked at $9.15K in Q2 2025.
37 funds tracked by Wall St. Rank held Evotec as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.